Clinical Trial Update: HIF-1α Stabilization As a Novel Therapeutical Approach for Sarcopenia. [NA]

View source ↗

Summary

This clinical trial investigates stabilization of HIF-1α as a novel therapeutic approach for sarcopenia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Snippet

Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Conditions: Sarcopenia | NA | Status: RECRUITING